Your session is about to expire
← Back to Search
Orthotic + Occupational Therapy for Cerebral Palsy
Study Summary
This trial aims to test the effectiveness of a special device that can help children with cerebral palsy who have limited use of their hands. The device is like a brace that can be worn on the arm
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any available openings for patients to participate in this medical study?
"Indeed, the information available on clinicaltrials.gov indicates that this study is actively seeking eligible participants. The trial was initially posted on January 1st, 2023 and recently updated on December 21st, 2023. With two sites involved in the trial, a total of 36 patients are being sought for enrollment."
Which individuals are eligible to participate in this clinical investigation?
"To be eligible for enrollment in this study, candidates must meet specific criteria. These include having a confirmed diagnosis of cerebral palsy and being between the ages of 4 and 17 years old. Additionally, participants should have moderate to severe hand disability as determined by the Manual Ability Classification System. Other requirements include active movement of the elbow, ability to follow instructions, and willingness to engage in goal-oriented activities and repetitive tasks."
Is the study actively seeking participants who are above the age of 50?
"To be eligible for enrollment in this study, participants must have an age between 4 and 17 years old."
How large is the participant pool in this medical study?
"Indeed, the information provided on clinicaltrials.gov confirms that this ongoing clinical trial is actively seeking eligible participants. The initial posting date for this study was January 1, 2023, and the most recent update occurred on December 21, 2023. The trial aims to enroll a total of 36 patients across two designated sites."
Share this study with friends
Copy Link
Messenger